Prevalência e determinantes do risco de sarcopenia em pessoas mais velhas: evidência de um estudo transversal

Autores

DOI:

https://doi.org/10.47197/retos.v75.118141

Palavras-chave:

Sarcopenia, fatores de risco, prevalência, preditores, idosos, estudo transversal

Resumo

Enquadramento/Objetivos: A sarcopenia está associada a múltiplas consequências negativas. O objetivo deste estudo foi explorar a prevalência do risco de sarcopenia e os seus possíveis fatores associados em adultos mais velhos na Hungria.

Métodos: Um total de 310 adultos maiores participam neste estúdio transversal. O protocolo do estudo foi registado em clinictrials.gov sob o identificador NCT05313360 a 28 de março de 2022. Os participantes preencheram um questionário que incluía dados demográficos, antecedentes médicos, estado nutricional, nível de atividade física, qualidade de vida relacionada com a saúde e estado geral de saúde. O questionário SARC-F foi utilizado para avaliar o risco de sarcopenia entre os participantes.

Resultados: Os resultados mostram que a prevalência do risco de sarcopenia foi de 26,8%. Os preditores no modelo de regressão univariada incluem a idade (p < 0,001), o número de medicamentos (p < 0,001), o número de consultas (p < 0,001), o número de consultas médicas de ambulatório (p = 0,001), a pontuação do MNA-SF (p < 0,001) e a pontuação do GPAQ (p < 0,001). 0,001). Tras controlando a idade no Bloco 1 (R² = 0,295), o modelo de regressão linear jerárquica multivariado (Bloque 2, R² = 0,483) mostrou que o número de medicamentos (p = 0,013), o número de doenças (p = 0,007), a pontuação do MNA-SF (p < 0,001) e la pontuação total do GPAQ (p = 0,004) foi um indicador independente significativo de um maior risco de sarcopenia.

Conclusão: O número de medicamentos, o número de doenças, o MNA-SF e as pontuações totais do GPAQ predisseram de forma significativa o risco de sarcopenia. Se recomendam estudos longitudinais adicionais para examinar o desenvolvimento da sarcopenia ao longo do tempo.

Referências

Ács, P., Betlehem, J., Oláh, A., Bergier, B., Morvay-Sey, K., Makai, A., & Prémusz, V. (2020). Cross-cultural adaptation and validation of the Global Physical Activity Questionnaire among healthy Hungarian adults. BMC Public Health, 20(1), 1056. https://doi.org/10.1186/s12889-020-08477-z

Aguilar-Farias, N., & Leppe Zamora, J. (2017). Is a single question of the Global Physical Activity Questionnaire (GPAQ) valid for measuring sedentary behaviour in the Chilean population? Journal of Sports Sciences, 35(16), 1652–1657. https://doi.org/10.1080/02640414.2016.1229010

Arisanti, R. R. S., Purwanto, B., Tinduh, D., Wiyasihati, S. I., & Yusuf, H. (2026). Sarcopenia markers, physical performance and sleep quality among high-risk students. Retos, 74, 246–257. https://doi.org/10.47197/retos.v74.117311

Azzolina, D., Vedovelli, L., Gallipoli, S., French, M., Ghidina, M., Lamprecht, M., Tsiountsioura, M., Lorenzoni, G., & Gregori, D. (2020). Nutrients and Caloric Intake Associated with Fruits, Vegetables, and Legumes in the Elderly European Population. Nutrients, 12(9), 2746. https://doi.org/10.3390/nu12092746

Bano, G., Trevisan, C., Carraro, S., Solmi, M., Luchini, C., Stubbs, B., Manzato, E., Sergi, G., & Veronese, N. (2017). Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas, 96, 10–15. https://doi.org/10.1016/j.maturitas.2016.11.006

Beaudart, C., Demonceau, C., Reginster, J., Locquet, M., Cesari, M., Cruz Jentoft, A. J., & Bruyère, O. (2023). Sarcopenia and health‐related quality of life: A systematic review and meta‐analysis. Journal of Cachexia, Sarcopenia and Muscle, 14(3), 1228–1243. https://doi.org/10.1002/jcsm.13243

Beaudart, C., Locquet, M., Reginster, J.-Y., Delandsheere, L., Petermans, J., & Bruyère, O. (2018). Quality of life in sarcopenia measured with the SarQoL®: Impact of the use of different diagnosis definitions. Aging Clinical and Experimental Research, 30(4), 307–313. https://doi.org/10.1007/s40520-017-0866-9

Bernabei, R., Lattanzio, F., & Paolisso, G. (2012). Adverse Drug Events in Older Geriatric Patients. Drug Safety, 35(1), 1–2. https://doi.org/10.1007/BF03319098

Bull, F. C., Maslin, T. S., & Armstrong, T. (2009). Global Physical Activity Questionnaire (GPAQ): Nine Country Reliability and Validity Study. https://doi.org/10.1123/jpah.6.6.790

Concha-Cisternas, Y., Guzmán-Muñoz, E., Sepúlveda-Loyola, W., Jofré-Saldía, E., Álvarez-Bustos, A., Sepúlveda, R. Y., & Valdés-Badilla, P. (2026). Factores asociados a sarcopenia en personas mayores autovalentes: Un estudio transversal. Retos, 74, 276–288. https://doi.org/10.47197/retos.v74.116807

Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M., Zamboni, M., & European Working Group on Sarcopenia in Older People. (2010). Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing, 39(4), 412–423. https://doi.org/10.1093/ageing/afq034

Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., & Zamboni, M. (2019). Sarcopenia: Revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16–31. https://doi.org/10.1093/ageing/afy169

Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., & Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. (2019). Sarcopenia: Revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16–31. https://doi.org/10.1093/ageing/afy169

de, C. M. (2020). Developing a simple global physical activity questionnaire for population studies. Australasian Epidemiologist, 9(2), 6–9. https://doi.org/10.3316/informit.432366132879428

Debes, W. A., Sadaqa, M., Németh, Z., Aldardour, A., Prémusz, V., & Hock, M. (2024). Effect of Resistance Exercise on Body Composition and Functional Capacity in Older Women with Sarcopenic Obesity—A Systematic Review with Narrative Synthesis. Journal of Clinical Medicine, 13(2), Article 2. https://doi.org/10.3390/jcm13020441

Elm, E. von, Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, for the S. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PLOS Medicine, 4(10), e296. https://doi.org/10.1371/journal.pmed.0040296

Fernández, J. A., Farfán, D. C., & Cuartas, L. A. H. (2025). Condición física funcional, riesgo de sarcopenia, fuerza prensil y deterioro cognitivo en mujeres mayores físicamente activas. Retos, 73, 1199–1219. https://doi.org/10.47197/retos.v73.117099

Fonfría-Vivas, R., Pérez-Ros, P., Barrachina-Igual, J., Pablos-Monzó, A., & Martínez-Arnau, F. M. (2023). Assessing quality of life with SarQol is useful in screening for sarcopenia and sarcopenic obesity in older women. Aging Clinical and Experimental Research, 35(10), 2069–2079. https://doi.org/10.1007/s40520-023-02488-7

Gajda, R., Jeżewska-Zychowicz, M., Raczkowska, E., Rak, K., Szymala-Pędzik, M., Noculak, Ł., & Sobieszczańska, M. (2024). Association of Dietary Patterns, Suspected Sarcopenia, and Frailty Syndrome among Older Adults in Poland—A Cross-Sectional Study. Nutrients, 16(18), 3090. https://doi.org/10.3390/nu16183090

Gao, Q., Hu, K., Yan, C., Zhao, B., Mei, F., Chen, F., Zhao, L., Shang, Y., Ma, Y., & Ma, B. (2021). Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. Nutrients, 13(12), Article 12. https://doi.org/10.3390/nu13124291

Gasparik, A. I., Demián, M.-B., Pascanu, I. M., Merlan, I., Hodinka, L., & Vereckei, E. (2020a). [Evaluation of the Hungarian-language SARC-F sarcopenia-screening questionnaire]. Orvosi Hetilap, 161(47), 2000–2005. https://doi.org/10.1556/650.2020.31932

Gasparik, A. I., Demián, M.-B., Pascanu, I. M., Merlan, I., Hodinka, L., & Vereckei, E. (2020b). [Evaluation of the Hungarian-language SARC-F sarcopenia-screening questionnaire]. Orvosi Hetilap, 161(47), 2000–2005. https://doi.org/10.1556/650.2020.31932

Geerinck, A., Demián, M.-B., Beaudart, C., & Gasparik, A.-I. (2022). Validation of the Hungarian Version of the SarQoL® Questionnaire and Its Association with the SARC-F Screening Tool. The Journal of Frailty & Aging, 11(3), 267–273. https://doi.org/10.14283/jfa.2021.53

Hämäläinen, O., Tirkkonen, A., Savikangas, T., Alén, M., Sipilä, S., & Hautala, A. (2024). Low physical activity is a risk factor for sarcopenia: A cross-sectional analysis of two exercise trials on community-dwelling older adults. BMC Geriatrics, 24(1), 212. https://doi.org/10.1186/s12877-024-04764-1

Hirani, V., Blyth, F., Naganathan, V., Couteur, D. G. L., Seibel, M. J., Waite, L. M., Handelsman, D. J., & Cumming, R. G. (2015). Sarcopenia Is Associated With Incident Disability, Institutionalization, and Mortality in Community-Dwelling Older Men: The Concord Health and Ageing in Men Project. Journal of the American Medical Directors Association, 16(7), 607–613. https://doi.org/10.1016/j.jamda.2015.02.006

Hoang, D. K., Doan, M. C., Le, N. M., Nguyen, H. G., Ho‐Pham, L. T., & Nguyen, T. V. (2023). Prevalence of and risk factors for sarcopenia in community‐dwelling people: The Vietnam Osteoporosis Study. Journal of Cachexia, Sarcopenia and Muscle, 15(1), 380–386. https://doi.org/10.1002/jcsm.13383

Jensen, L. D., Andersen, O., Hallin, M., & Petersen, J. (2014). Potentially inappropriate medication related to weakness in older acute medical patients. International Journal of Clinical Pharmacy, 36(3), 570–580. https://doi.org/10.1007/s11096-014-9940-y

Kim, J. Y., Oh, S., Park, H. Y., Jun, J. H., & Kim, H. J. (2020). Author Correction: Comparisons of different indices of low muscle mass in relationship with cardiometabolic disorder. Scientific Reports, 10(1), 750. https://doi.org/10.1038/s41598-020-57828-8

König, M., Spira, D., Demuth, I., Steinhagen-Thiessen, E., & Norman, K. (2018). Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II. The Journals of Gerontology: Series A, 73(1), 117–122. https://doi.org/10.1093/gerona/glx074

Kuzuya, M. (2024). Drug-related sarcopenia as a secondary sarcopenia. Geriatrics & Gerontology International, 24(2), 195–203. https://doi.org/10.1111/ggi.14770

Liu, C., Wong, P. Y., Chung, Y. L., Chow, S. K.-H., Cheung, W. H., Law, S. W., Chan, J. C. N., & Wong, R. M. Y. (2023). Deciphering the “obesity paradox” in the elderly: A systematic review and meta-analysis of sarcopenic obesity. Obesity Reviews, 24(2), e13534. https://doi.org/10.1111/obr.13534

Locquet, M., Bruyère, O., Lengelé, L., Reginster, J. Y., & Beaudart, C. (2021). Relationship between smoking and the incidence of sarcopenia: The SarcoPhAge cohort. Public Health, 193, 101–108. https://doi.org/10.1016/j.puhe.2021.01.017

Malmstrom, T. K., & Morley, J. E. (2013). SARC-F: A Simple Questionnaire to Rapidly Diagnose Sarcopenia. Journal of the American Medical Directors Association, 14(8), 531–532. https://doi.org/10.1016/j.jamda.2013.05.018

Meng, S., He, X., Fu, X., Zhang, X., Tong, M., Li, W., Zhang, W., Shi, X., & Liu, K. (2024). The prevalence of sarcopenia and risk factors in the older adult in China: A systematic review and meta-analysis. Frontiers in Public Health, 12, 1415398. https://doi.org/10.3389/fpubh.2024.1415398

Mesinovic, J., Zengin, A., Courten, B. D., Ebeling, P. R., & Scott, D. (2019).

Sarcopenia and type 2 diabetes mellitus: A bidirectional relationship

. Diabetes, Metabolic Syndrome and Obesity, 12, 1057–1072. https://doi.org/10.2147/DMSO.S186600

Messier, V., Rabasa-Lhoret, R., Barbat-Artigas, S., Elisha, B., Karelis, A. D., & Aubertin-Leheudre, M. (2011). Menopause and sarcopenia: A potential role for sex hormones. Maturitas, 68(4), 331–336. https://doi.org/10.1016/j.maturitas.2011.01.014

Milewska, M., Przekop, Z., Szostak-Węgierek, D., Chrzanowska, M., Raciborski, F., Traczyk, I., Sińska, B. I., & Samoliński, B. (2022). Prevalence of Risk of Sarcopenia in Polish Elderly Population—A Population Study. Nutrients, 14(17), 3466. https://doi.org/10.3390/nu14173466

Nasso, R., D’Errico, A., Motti, M. L., Masullo, M., & Arcone, R. (2024). Dietary Protein and Physical Exercise for the Treatment of Sarcopenia. Clinics and Practice, 14(4), Article 4. https://doi.org/10.3390/clinpract14040117

Pacifico, J., Reijnierse, E. M., Lim, W. K., & Maier, A. B. (2021). The Association between Sarcopenia as a Comorbid Disease and Incidence of Institutionalisation and Mortality in Geriatric Rehabilitation Inpatients: REStORing health of acutely unwell adulTs (RESORT). Gerontology, 68(5), 498–508. https://doi.org/10.1159/000517461

Pana, A., Sourtzi, P., Kalokairinou, A., & Velonaki, V. S. (2022). Sarcopenia and polypharmacy among older adults: A scoping review of the literature. Archives of Gerontology and Geriatrics, 98, 104520. https://doi.org/10.1016/j.archger.2021.104520

Pap, Z., Kalabiska, I., Balogh, Á., & Bhattoa, H. P. (2022). Prevalence of sarcopenia in community dwelling outpatient postmenopausal Hungarian women. BMC Musculoskeletal Disorders, 23(1), 207. https://doi.org/10.1186/s12891-022-05167-2

Papadopoulou, S. K. (2020). Sarcopenia: A Contemporary Health Problem among Older Adult Populations. Nutrients, 12(5), 1293. https://doi.org/10.3390/nu12051293

Petermann-Rocha, F., Balntzi, V., Gray, S. R., Lara, J., Ho, F. K., Pell, J. P., & Celis-Morales, C. (2022). Global prevalence of sarcopenia and severe sarcopenia: A systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle, 13(1), 86–99. https://doi.org/10.1002/jcsm.12783

Riuzzi, F., Sorci, G., Arcuri, C., Giambanco, I., Bellezza, I., Minelli, A., & Donato, R. (2018). Cellular and molecular mechanisms of sarcopenia: The S100B perspective. Journal of Cachexia, Sarcopenia and Muscle, 9(7), 1255–1268. https://doi.org/10.1002/jcsm.12363

Rubenstein, L. Z., Harker, J. O., Salvà, A., Guigoz, Y., & Vellas, B. (2001). Screening for undernutrition in geriatric practice: Developing the short-form mini-nutritional assessment (MNA-SF). The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 56(6), M366-372. https://doi.org/10.1093/gerona/56.6.m366

Sadaqa, M., Debes, W. A., Németh, Z., Bera-Baka, Z., Vachtler-Szepesi, M., Nácziné Földes, L., Prémusz, V., & Hock, M. (2024). Multicomponent Exercise Intervention for Preventing Falls and Improving Physical Functioning in Older Nursing Home Residents: A Single-Blinded Pilot Randomised Controlled Trial. Journal of Clinical Medicine, 13(6), Article 6. https://doi.org/10.3390/jcm13061577

Sadaqa, M., Németh, Z., Makai, A., Prémusz, V., & Hock, M. (2023). Effectiveness of exercise interventions on fall prevention in ambulatory community-dwelling older adults: A systematic review with narrative synthesis. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1209319

Soós, R., Bakó, C., Gyebrovszki, Á., Gordos, M., Csala, D., Ádám, Z., & Wilhelm, M. (2024). Nutritional Habits of Hungarian Older Adults. Nutrients, 16(8), 1203. https://doi.org/10.3390/nu16081203

Tanaka, T., Akishita, M., Kojima, T., Son, B.-K., & Iijima, K. (2023). Polypharmacy with potentially inappropriate medications as a risk factor of new onset sarcopenia among community-dwelling Japanese older adults: A 9-year Kashiwa cohort study. BMC Geriatrics, 23(1), 390. https://doi.org/10.1186/s12877-023-04012-y

Tang, T.-C., Hwang, A.-C., Liu, L.-K., Lee, W.-J., Chen, L.-Y., Wu, Y.-H., Huang, C.-Y., Hung, C.-H., Wang, C.-J., Lin, M.-H., Peng, L.-N., & Chen, L.-K. (2018). FNIH-defined Sarcopenia Predicts Adverse Outcomes Among Community-Dwelling Older People in Taiwan: Results From I-Lan Longitudinal Aging Study. The Journals of Gerontology: Series A, 73(6), 828–834. https://doi.org/10.1093/gerona/glx148

Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019). Sarcopenia. Joint Bone Spine, 86(3), 309–314. https://doi.org/10.1016/j.jbspin.2018.08.001

Trinh, O. T. H., Nguyen, N. D., Dibley, M. J., Phongsavan, P., & Bauman, A. E. (2008). The prevalence and correlates of physical inactivity among adults in Ho Chi Minh City. BMC Public Health, 8, 204. https://doi.org/10.1186/1471-2458-8-204

Tzeng, P.-L., Lin, C.-Y., Lai, T.-F., Huang, W.-C., Pien, E., Hsueh, M.-C., Lin, K.-P., Park, J.-H., & Liao, Y. (2020). Daily lifestyle behaviors and risks of sarcopenia among older adults. Archives of Public Health, 78(1), 113. https://doi.org/10.1186/s13690-020-00498-9

Vanitcharoenkul, E., Unnanuntana, A., Chotiyarnwong, P., Laohaprasitiporn, P., Adulkasem, N., Asavamongkolkul, A., & Chandhanayingyong, C. (2024). Sarcopenia in Thai community-dwelling older adults: A national, cross-sectional, epidemiological study of prevalence and risk factors. BMC Public Health, 24(1), 311. https://doi.org/10.1186/s12889-024-17804-7

Xia, W., Luo, K., Gu, Z., Hu, J., Liu, X., & Xiao, Q. (2024). Correlational analysis of sarcopenia and multimorbidity among older inpatients. BMC Musculoskeletal Disorders, 25, 309. https://doi.org/10.1186/s12891-024-07412-2

Yuan, S., & Larsson, S. C. (2023). Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism: Clinical and Experimental, 144, 155533. https://doi.org/10.1016/j.metabol.2023.155533

Zhang, X., Zhang, W., Wang, C., Tao, W., Dou, Q., & Yang, Y. (2018). Sarcopenia as a predictor of hospitalization among older people: A systematic review and meta-analysis. BMC Geriatrics, 18(1), 188. https://doi.org/10.1186/s12877-018-0878-0

Downloads

Publicado

02-02-2026

Edição

Secção

Artigos de caráter científico: trabalhos de pesquisas básicas e/ou aplicadas.

Como Citar

A. Debes, W., Sadaqa, M., Elmahgoub, S., Aburub, A., Ács, P., Hock, M., & Prémusz, V. (2026). Prevalência e determinantes do risco de sarcopenia em pessoas mais velhas: evidência de um estudo transversal. Retos, 75, 306-318. https://doi.org/10.47197/retos.v75.118141